Several factors were significantly associated with OS, including molecular subtype, positive hormone receptor status (ER+ and PR+), nuclear grade, tumor size, axillary lymph node dissection, recurrence, prognostic stage (II–IV), and YY1 expression. The gene discussed is NR4A1; the disease is neoplasm.